Charles A. Rowland Jr

Insider Reports History

Location
Furlong, PA
Signature
/s/ Shawna-Gay White, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Charles A. Rowland Jr:

Company Role Class Num Shares Value Price $ Report Date Ownership
Viking Therapeutics, Inc. Director Common Stock, par value $0.00001 per share 33,150 $1,233,511 $37.21 02 Jan 2026 Direct
Blueprint Medicines Corp Director Common Stock 5,812 $523,080 $90.00 02 Jun 2021 Direct
Generation Bio Co. Director Stock Option (right to buy) 0 $275,400 $4.59 09 Feb 2026 Direct
Blueprint Medicines Corp Director Stock Option (Right to Buy) 4,500 $67,545 $15.01 02 Jun 2021 Direct
Nabriva Therapeutics plc Director Ordinary Shares 15,277 $22,916 $1.50 01 Aug 2022 Direct
Generation Bio Co. Director Common Stock 0 $0 $5.48 09 Feb 2026 Direct
Viking Therapeutics, Inc. Director Stock Option (Right to Buy) 20,400 02 Jan 2026 Direct
Orchard Therapeutics plc Director Ordinary Shares 0 $0.4591 24 Jan 2024 Direct
Orchard Therapeutics plc Director Stock Option (Right to Buy) 0 24 Jan 2024 Direct

Insider Reports Filed by Charles A. Rowland Jr

Symbol Company Period Transactions Value $ Form Type Role Filing Time
GBIO Generation Bio Co. 09 Feb 2026 8 $0 4 Director 09 Feb 2026, 17:41
VKTX Viking Therapeutics, Inc. 02 Jan 2026 2 $0 4 Director 05 Jan 2026, 20:25
VKTX Viking Therapeutics, Inc. 27 Oct 2025 7 -$1,827,638 4 Director 28 Oct 2025, 19:49
GBIO Generation Bio Co. 04 Jun 2025 1 $0 4 Director 06 Jun 2025, 16:05
VKTX Viking Therapeutics, Inc. 02 Jan 2025 1 $0 4 Director 06 Jan 2025, 20:13
GBIO Generation Bio Co. 06 Jun 2024 1 $0 4 Director 10 Jun 2024, 16:05
/report/000095017024007074-rowland-charles-a-jr-2024-01-24 Orchard Therapeutics plc 24 Jan 2024 3 $0 4 Director 24 Jan 2024, 17:25
VKTX Viking Therapeutics, Inc. 02 Jan 2024 1 $0 4 Director 04 Jan 2024, 21:27
GBIO Generation Bio Co. 01 Dec 2023 2 +$477,778 4 Director 05 Dec 2023, 16:30
/report/000120919123037904-rowland-charles-a-jr-2023-06-14 Orchard Therapeutics plc 14 Jun 2023 1 $0 4 Director 16 Jun 2023, 16:30
GBIO Generation Bio Co. 08 Jun 2023 1 $0 4 Director 12 Jun 2023, 16:15
VKTX Viking Therapeutics, Inc. 16 May 2023 3 -$956,800 4 Director 18 May 2023, 18:31
VKTX Viking Therapeutics, Inc. 03 Jan 2023 1 $0 4 Director 04 Jan 2023, 17:12
GBIO Generation Bio Co. 19 Sep 2022 1 +$82,845 4 Director 20 Sep 2022, 16:16
GBIO Generation Bio Co. 15 Sep 2022 2 +$276,241 4 Director 19 Sep 2022, 17:21
GBIO Generation Bio Co. 13 Sep 2022 2 +$127,404 4 Director 15 Sep 2022, 16:07
GBIO Generation Bio Co. 09 Jun 2022 1 $0 4 Director 13 Jun 2022, 16:05
/report/000120919122035007-rowland-charles-a-jr-2022-06-07 Orchard Therapeutics plc 07 Jun 2022 1 $0 4 Director 08 Jun 2022, 16:05
VKTX Viking Therapeutics, Inc. 03 Jan 2022 1 $0 4 Director 05 Jan 2022, 18:11
/report/000110465921100288-rowland-charles-a-jr-2021-08-02 Nabriva Therapeutics plc 02 Aug 2021 1 -$932 4 Director 04 Aug 2021, 21:05
/report/000110465921098427-rowland-charles-a-jr-2021-07-28 Nabriva Therapeutics plc 28 Jul 2021 2 $0 4 Director 30 Jul 2021, 20:21
/report/000120919121041507-rowland-charles-a-jr-2021-06-16 Orchard Therapeutics plc 16 Jun 2021 1 $0 4 Director 17 Jun 2021, 17:02
GBIO Generation Bio Co. 09 Jun 2021 1 $0 4 Director 11 Jun 2021, 16:09
BPMC Blueprint Medicines Corp 02 Jun 2021 2 $0 4 Director 04 Jun 2021, 16:16
/report/000110465922085790-rowland-charles-a-jr-2020-08-01 Nabriva Therapeutics plc 01 Aug 2020 1 -$1,487 4 Director 03 Aug 2022, 21:48